Now approved: HAEGARDA is indicated for patients 6 years of age and older.

223 DAYS. 0 ATTACKS.* THE RIGHT THERAPY MATTERS HAEGARDA is the HAE therapy that reduces attacks by 95%

* In a later analysis of 63 patients followed over an average of 1.5 years, the median time to first attack was 224 days. Although these results support the primary findings, the study was not designed in advance to measure the median days to first attack.

In the clinical trial, the median reduction in number of attacks in people receiving HAEGARDA 60 IU/kg vs placebo.

With HAEGARDA, HAE attacks were reduced by

arrow pointing downwards with 95 percent symbol

As a preventive therapy, HAEGARDA can effectively reduce the number of HAE attacks you experience.

Median reduction in number of attacks in patients receiving 60 IU/kg of HAEGARDA vs placebo.

Use of rescue medication was nearly eliminated by

You should always have HAE rescue medication available at all times in case of a breakthrough attack.

§Median reduction in rescue medication use in patients receiving 60 IU/kg of HAEGARDA vs placebo.

Replaces missing or nonworking C1-INH

HAEGARDA brings your working C1-INH levels back up and closer to normal, reducing your risk of an HAE attack.

approved for patients 6 years and older
question mark

What is HAE?

What should you know about HAE? Find essential information here.

LEARN MORE
number one

What makes HAEGARDA different?

See why HAEGARDA is the HAE product that may provide 223 days with 0 attacks.

KNOW HAEGARDA
right arrow

Starting HAEGARDA

Discover the convenience of a therapy you can administer yourself.

GET STARTED
haegarda icon

Stay in the know with HAEGARDA

Sign up to receive helpful information.
 

HAEGARDA UPDATES
information icon

Attend an informative event happening in your area

Register for dinner program events or convenient webinars.

SEE EVENTS

HAEGARDA ConnectSM

Quickly access resources, information, and support.

HAEGARDA CONNECTSM

Social signup

Be part of the HAEGARDA community! Follow us on social.

Share your journey

We want to hear about your HAE journey.

SUBMIT YOUR STORY
You are now leaving the current website.

Do you want to continue?